News

SciClone Reports First Quarter 2017 Financial Results

FOSTER CITY, Calif., May 10, 2017 /PRNewswire/ — SciClone Pharmaceuticals, Inc. (SCLN) today reported financial results for the quarter ended March 31, 2017.

  • Revenues: In the first quarter 2017, SciClone reported revenues of $42.9 million, compared to $36.5 million for the same period in 2016.
  • GAAP Diluted EPS: In the first quarter 2017, SciClone reported GAAP diluted earnings per share of $0.28, compared to $0.15 for the same period in 2016.
  • Non-GAAP Diluted EPS: In the first quarter 2017, SciClone reported non-GAAP diluted earnings per share of $0.31, compared to $0.19 for the same period in 2016.
2017-06-21T10:01:00+00:00